Exploring the complexity of compliance in schizophrenia

Issues in Mental Health Nursing

Volumn 23, Issue 5, 2002, Pages 513-528

  Pinikahana, Jaya ^a,d   Happell, Brenda ^a   Taylor, Mark ^b   Keks, Nicholas A ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b GARTNAVEL ROYAL HOSPITAL   (United Kingdom)

^c Boxhill Hospital   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; REVIEW; SCHIZOPHRENIA; TREATMENT REFUSAL;

HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT REFUSAL;

EID: 0036632791     PISSN: 01612840     EISSN: None     Source Type: Journal    
DOI: 10.1080/01612840290052677     Document Type: Article

References (101)

1. Adam, S. G., & Howe, J. T. (1993). Predicting medication compliance in a psychotic population. The Journal of Nervous and Mental Disease, 181, 558-560.
2. Adams, J., & Scott, J. (2000). Predicting medication adherence in severe mental disorders. Acta Psychiatrica Scandinavica, 101(2), 119-124.
3. Agarwal, M. R., Sharma, V. K., Kumr, H., & Lowe, D. (1998). Non-compliance with treatment in patients suffering from schizophrenia. International Journal of Social Psychiatry, 44, 92-106.
4. Amodor, X. F., Strauss, D. H., Yale, S. A., Flaum, M. M., Endicott, J., & Gorman, J. M. (1993). Assessment of insight in psychosis. American Journal of Psychiatry, 150, 873-879.
5. Angermeyer, M. C., & Matschinger, H. (1994). Lay beliefs about schizophrenic disorder: The results of a population survey in Germany. Acta Psychiatrica Scandinavica, 89, 39-45.
6. Atwood, N., & Beck, J. C. (1985). Service and patient predicators of continuation in clinic based treatment. Hospital and Community Psychiatry, 36, 865-869.
7. Ayers, T., Liberman, R. P., & Wallace, C. J. (1984). Subjective response to antipsychotic drugs: Failure to replicate predictions of outcome. Journal of Clinical Psychopharmacology, 4, 89-93.
8. Babiker, I. L. (1986). Noncompliance in schizophrenia. Psychiatric Developments, 4, 329-337.
9. Barns, T. R. L., Christopher, J., & McEvedy, B. (1996). Management of treatment resistant schizophrenia unresponsive to clozapine. British Journal of Psychiatry, 169, 31-40.
10. Bartko, G., Herezeg, I., & Zdor, G. (1988). Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatrica Scandinavica, 77, 74-76.
11. Bebbington, P. L. (1995). The content and context of compliance. International Clinical Psychopharmacology, 9, 41-50.
12. Becker, M. H., & Maiman, L. A. (1975). Sociobehavioural determinants of compliance with health and medical care recommendations. Medical Care, 1, 11-25.
13. Berg, J. S., Dischler, J., Wagner, D. J., & Raia, J. J. (1993). Medication compliance: A health care problem. Annals of Pharmacotherapy, 27, 5-24.
14. Blackwell, B. (1976). Treatment adherence. British Journal of Psychiatry, 129, 513-531.
15. Boczkowski, J. A., Zeichner, A., & DeSanto, N. (1985). Neuroleptic compliance among chronic schizophrenic outpatients. Journal of Consulting and Clinical Psychiatry, 53, 666-671.
16. Brown, C. S., Wright, R. G., & Christensen, D. B. (1987). Association between type of medication instruction and patients' knowledge, side effects and compliance. Hospital and Community Psychiatry, 38, 55-60.
17. Buchanan, A. (1992). A two year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine, 22, 787-797.
18. Buchanan, A. (1996). Compliance with treatment in schizophrenia. Maudsley Monograph, 37. London: Psychology Press.
19. Buchanan, A., & David, A. (1994). Compliance and the reduction of dangerousness. Journal of Mental Health, 3, 427-429.
20. Buchkremer, G., Stricken K., & Holle, R. (1991). The predictability of relapse in schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience, 240, 292-300.
21. Budd, R. J., Hughes, I. C. T., & Smith, J. A. (1996). Health beliefs and compliance with anti-psychotic medication. British Journal of Clinical Psychology, 35, 393-397.
22. Caspar, L. S., & Regan, J. R. (1993). Reasons for admission among six profile subgroups of recidivists of impatient services. Canadian Journal of Psychiatry, 38, 657-661.
23. Caton, C. L., Goldstein, J. M., Fleiss, J. L., Serrano, O., & Bender, R. (1984). The impact of discharge planning on chronic schizophrenic patients. Hospital and Community Psychiatry, 35, 255-262.
24. Chan, D. W. (1984). Medication compliance in a Chinese psychiatric out-patient setting. British Journal of Medical Psychology, 57, 81-89.
25. Churchill, D. N. (1985). Compliance: How to measure it. Modern Medicine in Candada, 40, 1068-1070.
26. Conway, S. P., Pond, M. N., & Hamnet, T. (1996). Compliance with treatment in adult patients with cystic fibrosis. Thorax, 51, 29-33.
27. Curson, D. A., Barnes, T. R. E., Bamber, R. W., Platt, S. D., Hirsch, S. R., & Duffy, J. C. (1985). Long-term depot maintenance of chronic schizophrenic out patients. British Journal of Psychiatry, 146, 464-480.
28. David, A. S. (1990). Insight and psychosis. British Journal of Psychiatry, 156, 798-808.
29. Davies, A., Adena, M. A., Keks, N. A., Catts, S. V., Lambert, J., & Schweitzer, N. (1998). Risperidone versus haloperidol: Meta-analysis of efficacy and safety. Clinical Therapeutics, 20(1), 58-71.
30. Davis, J. M., Janicak, P. G., Singla, A., & Sharma, R. P. (1993). Maintenance antipsychotic medication. In T. R. E. Barnes (Ed.), Anti-psychotic drugs and their side effects (pp. 93-98). New York: Academic.
31. Day, J. C., Wood, G., Dewey, M., & Bentall, R. P. (1995). A self rating scale for measuring neuroleptic side effects. British Journal of Psychiatry, 166, 650-653.
32. Dirks, J. F., & Kinsman, R. A. (1982). Nondichotomous patterns of medication usage: The yes no fallacy. Clinical Pharmacology and Therapeutics, 31, 413-417.
33. Dorevitch, A., Aronzon, R., & Zilberman, L. (1993). Medication maintenance of chronic schizophrenic out patients by a psychiatric clinical pharmacist: 10 year follow up study. Journal of Clinical Pharmacology and Therapeutics, 18, 183-186.
34. Drake, R. F., & Wallach, M. A. (1989). Substance abuse among the chronic mentally ill. Hospital and Community Psychiatry, 40, 1041-1046.
35. Dunbar, J. (1985). Adhering to medical advice. International Journal of Mental Health, 9, 70-87.
36. Duncan, J. C., & Rogers, R. (1998). Medication compliance in patients with chronic schizophrenia: Implications for the community management of mentally disordered offenders. Journal of Forensic Science, 43, 1133-1137.
37. Eckman, T. A., Liberman, R. P., Phipps, C. C., & Blair, K. E. (1990). Teaching medication management skills to schizophrenic patients. Journal of Clinical Psychopharmacology, 10, 33-38.
38. Falloon, I. R. H. (1984). Developing and maintaining adherence to long-term drug taking regimens. Schizophrenia Bulletin, 10, 412-417.
39. Falloon, I. R., Boyd, J. F., McGill, C. W., Williamson, M., Razani, J., & Moss, H. B. (1985). Family management in the prevention of morbidity of schizophrenia. Archives of General Psychiatry, 42, 887-896.
40. Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997). Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23, 637-651.
41. Frank, A., & Gunderson, J. (1990). The role of the therapeutic alliance in the treatment of schizophrenia. Archives of General Psychiatry, 47, 228-236.
42. Friedman, M. (1988). Compliance with chronic disease regimens. Journal of Diabetic Complications, 2, 140-144.
43. Gerlach, J. (1995). Depot neuroleptics in relapse prevention: Advantages and disadvantages. International Clinical Psychopharmacology, 9, 17-20.
44. Goldstein, M. J. (1992). Psychosocial strategies for maximizing the effects of psychotropic medications for schizophrenia and mood disorder. Psychopharmacology Bulletin, 28, 237-240.
45. Green, J. H. (1988). Frequent rehospitalization and noncompliance with treatment. Hospital and Community Psychiatry, 39, 963-966.
46. Herman, J. B., Brotman, A. W., & Pollack, M. H. (1990). Fluoxetine-induced sexual dysfunction. Journal of Clinical Psychiatry, 51, 25-27.
47. Harrison, O., Ineichen, H., Smith, J., & Morgan, H. G. (1984). Psychiatric hospital admissions in Bristol: Social and clinical aspects of compulsory admission. British Journal of Psychiatry, 145, 605-611.
48. Heyscue, B. E., Levin, G. M., & Merrick, J. P. (1998). Compliance with depot antipsychotic medication by patients attending outpatient clinics. Psychiatric Services, 49, 1232-1234.
49. Hoge, S. K., Appelbaum, P. S., Lawlor, T., Beck, J. C., Litman, R., & Greer, A. (1990). Prospective multi-centre study of patients' refusal of anti-psychotic medication. Archives of General Psychiatry, 47, 949-956.
50. Howard, A., & Reveley, A. (2000). Review of compliance in schizophrenia. Novartis, 10, 1-4.
51. Hughes, I., Hill, U., & Budd, R. (1997). Compliance with anti-psychotic medication: From theory to practice. Journal of Mental Health, 6, 473-489.
52. Kashner, T. M., Rader, L. H., Rodell, D. H., Beck, C. M., Rodell, L. R., & Muller, K. (1991). Family characteristics, substance abuse and hospitalization patterns of patients with schizophrenia. Hospital and Community Psychiatry, 42, 195-197.
53. Kelly, G. R., Mamon, J. A., & Scott, J. E. (1987). Utility of the Health Beliefs Model in examining medication compliance among psychiatric outpatients. Social Science and Medicine, 25, 1205-1211.
54. Kelly, G. R., & Scott, J. E. (1990). Medication compliance and health education among outpatients with chronic mental disorders. Medical Care, 28, 1181-1197.
55. Kemp, R., & David, A. (1995). Psychosis: Insight and compliance. Current Opinion in Psychiatry, 8, 357-361.
56. Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996). Compliance therapy in psychotic patients: A randomised controlled trial. British Medical Journal, 312, 345-349.
57. Kemp, R., Hayward, P., & David, A. (1997). Compliance therapy manual. London: Institute of Psychiatry.
58. Kovasznay, B., Fleischer, J., Tanesberg, K. M., Jandorf, L., Miller, A. P., & Bromet, E. (1997). Substance use disorder and the early cause of illness in schizophrenia and affected psychosis. Schizophrenia Bulletin, 23, 195-204.
59. Levy, P., & Llewellyn, S. (1995). Improving patients' understanding, recall, satisfaction and compliance. In A. Broom & S. Llewellyn (lids.). Health psychology: Process and Applications. London: Croom Helm.
60. Lin, I. F., Spiga, R., & Fortsch, W. (1979). Insight and adherence to medication in chronic schizophrenics. Journal of Clinical Psychiatry, 40, 430-432.
61. Ludwig. W., Huber D., Schmidt, S., Bender, W., & Greil, W. (1990). Assessment of compliance related attitudes in psychiatry. Social Psychiatry and Psychiatric Epidemiology, 25, 298-303.
62. Lysaker, P., Bell, M., Milstein, R., Bryson, G., & Beamgoulef, J. (1994). Insight and psychosocial treatment compliance in schizophrenia. Psychiatry, 57, 307-315.
63. Macpherson, R., & Jerrom, B. (1997). Drug refusal among schizophrenic patients treated in the community. Journal of Mental Health, 6, 141-147.
64. Marder, S. R., Mebane, A., Chien, C., Winslade, W. J., & Swann, J. D. (1983). A comparison of patients who refuse and consent to neuroleptic treatment. American Journal of Psychiatry, 140(4), 470-472.
65. McEvoy, J. P., Freter, S., & Everett, G. (1989). Insight and the clinical outcome of schizophrenic patients. Journal of Nervous Mental Disease, 177, 48-51.
66. Munetz, M. R., & Roth, L. H. (1985). Informing patients about tardive dyskinesia. Archives of General Psychiatry, 42, 866-871.
67. Naher, D., Holzbach, R., Perro, C., & Hippius, H. (1992). Clinical management of clozapine patients in relation to ellicacy and side-effects. British Journal of Psychiatry, 160, 54-59.
68. Nelson, A. A., Gold, B. H., Huchinson, R. A., & Benezra, F. (1975). Drug default among schizophrenic patients. American Journal of Hospital Pharmacy, 32, 1237-1242.
69. Norell, S. F. (1981). Accuracy of patient interviews and estimates of clinical staff in determining medication compliance. Social Science and Medicine, 15, 59-61.
70. Olarate, S. W., & Masnik, R. (1981). Enhancing medication compliance in coffee groups. Hospital and Community Psychiatry, 32, 417-419.
71. Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. J. (2000). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51, 216-222.
72. Owen, R. R., Fischer, F. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47, 853-858.
73. Pan, P. C., & Tantam, D. (1989). Clinical characteristics, health beliefs and compliance with maintenance treatment: A comparison between regular and irregular attenders at a depot clinic. Acta Psychiatrica Scandinavica, 79, 564-570.
74. Parashos, I. A., Xiromeritis, K., Zoumbou, V., Stamouli, S., & Theodotou, R. (2000). The problem of non-compliance in schizophrenia: Opinions of patients and their relatives. International Journal of Psychiatry in Clinical Practice, 4, 147-150.
75. Pennington, D. C. (1990). Essential social psychology. London: Edward Arnold.
76. Perkins, R. F., & Moodley, P. (1993). Perception of problems in psychiatric inpatients: Denial, race and service use. Social Psychiatry and Psychiatric Epidemiology, 28, 189-193.
77. Pool, F. V., & Elder, S. T. (1986). A selected review of the literature on an empirical analysis of drug treatment compliance by schizophrenic patients. International Review of Applied Psychology, 35, 547-576.
78. Pristach, C. A., & Smith, C. M. (1990). Medication compliance and substance abuse among schizophrenic patients. Hospital and Community Psychiatry, 41, 1345-1348.
79. Razali, M. S., & Yahya, H. (1995). Compliance with treatment in schizophrenia: A drug intervention program in a developing country. Acta Psychiatrica Scandinavica, 91, 331-335.
80. Reilly, E. L., Wilson, W. P., & McClinton, H. K. (1967). Clinical characteristics and medication history of schizophrenics readmitted to the hospital. International Journal of Neuropsychiatry, 39, 85-90.
81. Renton, C. A., Affleck, J. W., Carstairs, G. M., & Forrest, A. D. (1963). A follow up of schizophrenic patients in Edinburgh. Acta Psychiatrica Scandinavica, 39, 548-600.
82. Rosenstock, I. M. (1966). Why people use health services. Millbank Memorial Fund Quarterly, 44, 94-127.
83. Ruscher, S. M., Wit, R., & Mazmanian, D. (1997). Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatric Services, 48, 82-85.
84. Salloum, I. M., Moss, H. B., & Daley, D. C. (1991). Substance abuse and schizophrenia: Impediments to optimal care. American Journal of Drug and Alcohol Abuse, 17, 321-336.
85. Sellwood, W., & Tarrier, N. (1994). Demographic factors associated with extreme non-compliance in schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 29, 172-177.
86. Seltzer, A., Roncari, I., & Garfinkel, P. (1980). Effect of patient education on medication compliance. Canadian Journal of Psychiatry, 25, 639-645.
87. Silverstone, T., Smith, G., & Goodall, E. (1988). Prevalence of obesity in patients receiving depot anti-psychotics. British Journal of Psychiatry, 153, 214-217.
88. Smith, C. M., Barzman, D., & Pristach, C. A. (1997). Effect of patient and family insight on compliance of schizophrenia. Journal of Clinical Pharmacology, 37, 147-154.
89. Smith, L. D. (1989). Medication refusal and the rehospitalized mentally ill inmate. Hospital and Community Psychiatry, 40, 491-496.
90. Soskis, D. A. (1978). Schizophrenic and medical inpatients as informed drug consumers. Archives of General Psychiatry, 35, 645-647.
91. The Scottish Schizophrenia Group. (1987). The Scottish first episode schizophrenia study. Treatment: Pimozide versus flupenthixol. British Journal of Psychiatry, 150, 334-338.
92. Trauer, T., & Sacks, T. (1998). Medicalion compliance: A comparison of the views of severely mentally ill clients in the community, their doctors and their case managers. Journal of Mental Health, 7, 621-629.
93. Tunnicliffe, S., Harrison, G., & Standen, P. J. (1992). Factors affecting compliance with depot injection treatment in the community. Social Psychiatry and Psychiatric Epidemiology, 27, 230-233.
94. Van Putten, T. (1974). Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry, 31, 67-72.
95. Van Putten, T., Crumpton, H., & Yale, C. (1976). Drug refusal in schizophrenia and the wish to be crazy. Archives of General Psychiatry, 33, 1443-1446.
96. Van Putten, T., May, P. R., Marder, S. R., & Wittmann, L. A. (1981). Subjective response to anti-psychotic drugs. Archives of General Psychiatry, 38, 187-190.
97. Verghese, A., John, J. K., Rajkumar, S., Richard, J., Sethi, B. B., & Trivedi, J. K. (1989). Factors associated with the course and outcome of schizophrenia in India: Results of a two year multicentre follow-up study. British Journal of Psychiatry, 154, 499-503.
98. Willcox, D. R. C., Gillan, R., & Hare, E. H. (1965). Do psychiatric out patients take their drugs? British Medical Journal, 2, 199-206.
99. Wilson, J. D., & Enoch, M. D. (1967). Estimation of drug rejection by schizophrenic in patients with analysis of clinical factors. British Journal of Psychiatry, 113, 209-211.
100. Young, J. L., Zonana, H. V., & Shepler, L. (1986). Medication non-compliance in schizophrenia: Codification and update. Bulletin of the Amen can Academy of Psychiatry and Law, 14, 105-122.
101. Zito, J. M., Routt, W. W., Mitchell, J. E., & Roerig J. L. (1985). Clinical characteristics of hospitalized psychotic patients who refuse anti-psychotic drug therapy. American Journal of Psychiatry, 142(1), 822-826.